Skip to main content
OpenTrials
Completed

NCT Number: NCT02015689

Altruistically Framed Messages and Impact on Parents' Reported Willingness to Immunize Their Children

The purpose of this study is to examine the impact of different message framing (i.e., communication strategies) on parents' intentions to vaccinate their infants for measles, mumps, and rubella. We hypothesize that information specifically emphasizing various benefits of MMR vaccination will have different impacts on parents' reported levels of intention.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

The purpose of this study is to investigate attitudes concerning the Measles, Mumps, & Rubella (MMR) vaccine among adult parents in the United States. Attitudes will be assessed via a web-based survey administered by Survey Sampling International (SSI). Project sample size is 1,000, all to be recruited by SSI. The survey will take no more than 20-30 minutes to complete. The survey questions and response options attached. With the exception of demographic questions (e.g., age, sex, race) at the end of the survey, questions will not be able to be "skipped" because 1) the survey questions primarily assess attitudes and beliefs, 2) the questions are not of a sensitive nature, 3) responses are anonymous, 4) respondents have indicated their desire and willingness to respond to surveys like this by virtue of their enrollment as an SSI panel member, 5) there is no pressure for respondents to complete the survey, 6) respondents may cease responding to the survey at any time after they begin.

Respondents will be asked to provide information about their children's ages and sex, as well as historical recall information about their past vaccine decisions for their child/children. All respondents will receive general information from the Centers for Disease Control and Prevention (CDC) regarding MMR and the MMR vaccine (taken from the CDC's Vaccine Information Sheet), followed by summarized information about MMR and the MMR vaccine. A quarter of respondents will receive only this information. The other three-quarters of respondents will also receive additional "benefit" information that either underscores: a) the MMR vaccine's benefit to the child who receives it, b) the MMR vaccine's benefits to society as a whole, or c) the MMR vaccine's benefit to both the child who receives it as well as to society as a whole. The purpose of this additional "benefit" information (which will randomly vary among respondents) is to compare people's attitudes when they're given this information about the MMR vaccine's benefit to people's attitudes when they receive the general information. This information is noted in the attached survey, and mimics the information that parents are typically given in clinic settings regarding MMR and the MMR vaccine. The purpose of this study is to systematically assess people's responses to this information, which is already offered in clinical settings and is publicly available via the CDC.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years of age or older
  • fluent in English
  • parent or primary caregiver to at least 1 child 17 years of age or younger

Exclusion criteria

  • not fluent in English
  • younger than 18 years of age
  • not a parent or primary caregiver to someone 17 years of age or younger

Treatment and study plan

Benefits to Child

Behavioral

CDC VIS + message emphasizing benefits to child of MMR vaccine

Benefits to Society

Behavioral

CDC VIS + message emphasizing benefits to society of MMR vaccine

Benefits to Child and Society

Behavioral

CDC VIS + message emphasizing benefits both to child and to society of MMR vaccine

CDC VIS

Behavioral

CDC Vaccine Information Statement (VIS)

Primary outcomes

  1. Parental MMR Vaccine Intentions for Their Children

    Time frame: Outcome (MMR intention) is measured immediately after participant receives message; measurement is immediate (not longitudnal follow-up)

    Participants report their willingness to vaccinate their infant for measles, mumps, and rubella on an 11-point scale anchored at 0(not at all likely) and 100(extremely likely) per the following prompt:

    On the scale below, please indicate how likely you are to have your baby receive the MMR vaccine.

Sponsors and collaborators

Lead sponsor

Indiana University

Other

Registry information

Important dates

Study start
2012
Primary completion
2012
Study completion
2012
First posted
Dec 19, 2013
Registry last updated
Dec 19, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.